2010
DOI: 10.1002/hed.21315
|View full text |Cite
|
Sign up to set email alerts
|

Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase

Abstract: Background. In accord with the cancer stem cell (CSC) theory, only a small subset of cancer cells are capable of forming tumors. We previously reported that CD44 isolates tumorigenic cells from head and neck squamous cell cancer (HNSCC). Recent studies indicate that aldehyde dehydrogenase (ALDH) activity may represent a more specific marker of CSCs.Methods. 1 Despite advances in therapy that have improved quality of life, survival rates have remained static for many years. Mortality from this disease remains h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
342
1
13

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 400 publications
(366 citation statements)
references
References 27 publications
10
342
1
13
Order By: Relevance
“…In a review performed by Januchowski et al, the association between high level expression of ALDH1A1 and poor prognosis was shown in breast (Black et al, 2009;Tanei et al, 2009), bladder and prostate cancer patients (Li et al, 2010). It has also been shown to be a marker of CSCs in many types of solid tumors, including liver (Lingala et al, 2010), head and neck (Clay et al, 2010), pancreas (Rasheed et al, 2010), lung (Rasheed et al, 2010) ovary (Deng et al, 2010), and colon carcinomas (Lugli et al, 2010). Similar results were reported by Tanei et al in another study on breast cancer indicating the association between high expression of ALDH1A1 with lower overall survival and increase the number of ALDH1A1+ cells after chemptherapy (Tanei et al, 2009), since chemotherapy cannot eradicate cancer stem cells (CSCs) expressing ALDH1A1.…”
Section: Discussionmentioning
confidence: 99%
“…In a review performed by Januchowski et al, the association between high level expression of ALDH1A1 and poor prognosis was shown in breast (Black et al, 2009;Tanei et al, 2009), bladder and prostate cancer patients (Li et al, 2010). It has also been shown to be a marker of CSCs in many types of solid tumors, including liver (Lingala et al, 2010), head and neck (Clay et al, 2010), pancreas (Rasheed et al, 2010), lung (Rasheed et al, 2010) ovary (Deng et al, 2010), and colon carcinomas (Lugli et al, 2010). Similar results were reported by Tanei et al in another study on breast cancer indicating the association between high expression of ALDH1A1 with lower overall survival and increase the number of ALDH1A1+ cells after chemptherapy (Tanei et al, 2009), since chemotherapy cannot eradicate cancer stem cells (CSCs) expressing ALDH1A1.…”
Section: Discussionmentioning
confidence: 99%
“…1 Recently, the EMT has been found to contribute to the progression and confer cancer cells with stem cell-like properties, in which the cells have a propensity for invasion, metastatic dissemination, resistance to certain therapy, persistence in tumours, and recurrence. 19,28 Understanding the molecular and cellular changes may generate novel targets that can overcome the aforementioned issues and reduce mortality. In this study, we made three novel observations that may help develop new treatments for OSCC: overexpression of Snail induced the SCC9 cells to undergo EMT; furthermore, these cells exhibited mesenchymal properties and were highly invasive, but not highly proliferative; and the induction of EMT conferred CSC-like properties to these mesenchymal cells.…”
Section: Discussionmentioning
confidence: 99%
“…ALDH1, a detoxifying enzyme responsible for the oxidation of intracellular aldehydes, is also considered to be a common marker for both normal stem cells and malignant CSCs from HNSCC (10,24,25). Overexpression of both CD44v3 and ALDH1 appears to be closely associated with CSC-mediated HNSCC development and progression (10).…”
Section: Isolation Of a Highly Tumorigenic Cell Population From Tumormentioning
confidence: 99%